SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: Findit who wrote (9282)5/12/1998 8:26:00 AM
From: b muller  Respond to of 14328
 
Ron
Chart looks fantastic from here. I would bet a break out past 2 5/8 would see a run past 3. All this should happen this week

This is the avit man another chart thats worth watching

b



To: Findit who wrote (9282)5/12/1998 9:55:00 AM
From: Scott H. Davis  Read Replies (1) | Respond to of 14328
 
My TA assessment is a mixed bag with most indicators recently starting to trend bullishly. The chart pattern from March is that of a wedge. Rainier Trinidad has an excellent homepage with explainations of several chart formations, including "the wedge" (see The Rational Analyst thread for more details) Draw lines down from the tops of the descending high, and ascending lows to see a coming intersection. In summary, it means the market is coming to a point of decision, and when it reaches it, price change is usually dramatic, but there is no advance predictor as far as which way.

RSI, Momentum and Wiliams %R are crossing the midpoint and heading up.
Fast Stochastics has crossed slow, moving up at the midpoint also. MACD looks like it is about to have a positive divergance. On Balance Volume has turned back up, but money flow is nasty.

So most indicators are moving in the right direction. TRIBY is neither overbought nor oversold right now. I don't have access to top of the line TA software (I will purchase some after I finish some other areas of education & tend to some homefront neglect). Rainier could probably supply a more exact assessment, but I don't see a definitive big upside breakout comming. As I see it, Scott